26 September 2023
26 September 2023
Clinical trials of at-home ECG monitoring device, SmartHeart, show decreased hospitalisation rates in post-MI patients.
Mentions of AI in relation to the pharmaceutical sector reached a peak in Q3 2023.
The companies aim to provide new solutions for research sites, contract research organisations (CROs) and sponsors.
Anebulo will initiate two trials in different settings that may lead to regulatory approval for its ANEB-001.
Phase Ia of the trial is expected to be completed in the first half of next year.
Luminate is an integrin regulator that controls several pathways of oxidative stress response.
ASC40 has also been designed to treat acne and non-alcoholic steatohepatitis.
The trial will assess NDM670's safety, tolerability and efficacy in ambulatory adult patients with SMA Type III.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
